CA
LMAT icon

Crewe Advisors’s LeMaitre Vascular LMAT Stock Holding History

Crewe Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.8K Buy
209
+66
+46% +$6.29K ﹤0.01% 496
2025
Q4 		$11.6K Buy
143
+15
+12% +$1.29K ﹤0.01% 596
2025
Q3 		$11.2K Buy
+128
New +$11.4K ﹤0.01% 609
2024
Q3 		– Sell
-253
Closed -$20.8K – 869
2024
Q2 		$20.8K Buy
253
+186
+278% +$13.7K ﹤0.01% 545
2024
Q1 		$4.45K Buy
+67
New +$4.13K ﹤0.01% 748
2023
Q2 		– Sell
-435
Closed -$22.4K – 962
2023
Q1 		$22.4K Hold
435
– – ﹤0.01% 412
2022
Q4 		$20K Hold
435
– – ﹤0.01% 424
2022
Q3 		$22K Hold
435
– – ﹤0.01% 443
2022
Q2 		$20K Buy
+435
New +$19.5K ﹤0.01% 419

Other funds holding LMAT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM